Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRBPCRBP
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CORBUS PHARMACEUTICALS HLDGS

GOLDMAN SACHS GROUP INC holds 62,863 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $589,655 as of 2026-Q2. The position was decreased (-32.5% shares). CRBP represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$589,655

Current Shares

62,863

Total Value Change

-$84,998

Total Shares Change

+5,689

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
62,863
-32.5%
$589,6550.0%$9.38
0
2026-Q1
Increased
93,111
+96.3%
$874,3130.0%$8.21
40
2025-Q4
Increased
47,438
+42.2%
$386,1450.0%$8.01
22
2025-Q3
Decreased
33,352
-23.6%
$421,9030.0%$12.26
0
2025-Q2
Decreased
43,674
-24.6%
$301,3510.0%$7.40
0
2025-Q1
Increased
57,936
+1.3%
$307,6410.0%$5.52
16
2024-Q4
New
57,174
-
$674,6530.0%$12.08
34

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used